Doan Dieu T, Strebeck Paige V, Tran Andrew D, Farrar Jason E, Appell Lauren E, Modi Arunkumar J, Jefferson Akilah A
Division of Allergy and Immunology, Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.
Division of Hematology and Oncology, Department of Pediatrics, University of Arkansas for Medical Sciences, Arkansas Children's Hospital Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Ark.
J Allergy Clin Immunol Glob. 2024 Jul 26;3(4):100313. doi: 10.1016/j.jacig.2024.100313. eCollection 2024 Nov.
Prompt evaluation and genetic testing of patients who present with recurrent and recalcitrant warts, before onset of severe infection or myelodysplastic syndrome, leads to improved outcomes in patients with GATA2 deficiency.
在严重感染或骨髓增生异常综合征发作之前,对出现复发性和顽固性疣的患者进行及时评估和基因检测,可改善GATA2缺乏症患者的预后。